These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2574230)

  • 41. Tardive dyskinesia, dopamine receptors, and neuroleptic damage to cell membranes.
    Seeman P
    J Clin Psychopharmacol; 1988 Aug; 8(4 Suppl):3S-9S. PubMed ID: 2906067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of severe axial tardive dystonia with clozapine: case report and hypothesis.
    Trugman JM; Leadbetter R; Zalis ME; Burgdorf RO; Wooten GF
    Mov Disord; 1994 Jul; 9(4):441-6. PubMed ID: 7969212
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 76Br-bromospiroperidol: a new tool for quantitative in-vivo imaging of neuroleptic receptors.
    Mazière B; Loc'h C; Hantraye P; Guillon R; Duquesnoy N; Soussaline F; Naquet R; Comar D; Mazière M
    Life Sci; 1984 Sep; 35(13):1349-56. PubMed ID: 6332966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia.
    Bordia T; Zhang D; Perez XA; Quik M
    Exp Neurol; 2016 Dec; 286():32-39. PubMed ID: 27658674
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurochemical basis for the absence of overt "stereotyped" behaviors in rats with up-regulated striatal D2 dopamine receptors.
    Fields JZ; Drucker GE; Wichlinski L; Gordon JH
    Clin Neuropharmacol; 1991 Jun; 14(3):199-208. PubMed ID: 1676931
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels.
    Mela F; Marti M; Bido S; Cenci MA; Morari M
    Neurobiol Dis; 2012 Jan; 45(1):573-82. PubMed ID: 22001605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Amphetamine-induced dopamine release and post-synaptic specific binding in patients with mild tardive dyskinesia.
    Adler CM; Malhotra AK; Elman I; Pickar D; Breier A
    Neuropsychopharmacology; 2002 Mar; 26(3):295-300. PubMed ID: 11850144
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients.
    Chouinard G; Annable L; Ross-Chouinard A
    Psychopharmacol Bull; 1986; 22(3):891-6. PubMed ID: 2879310
    [No Abstract]   [Full Text] [Related]  

  • 50. A double-injection technique for in vivo measurement of dopamine D2-receptor density in monkeys with 3-(2'-[18F]fluoroethyl)spiperone and dynamic positron emission tomography.
    Huang SC; Bahn MM; Barrio JR; Hoffman JM; Satyamurthy N; Hawkins RA; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):850-8. PubMed ID: 2531148
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Affinity States of Striatal Dopamine D2 Receptors in Antipsychotic-Free Patients with Schizophrenia.
    Kubota M; Nagashima T; Takano H; Kodaka F; Fujiwara H; Takahata K; Moriguchi S; Kimura Y; Higuchi M; Okubo Y; Takahashi H; Ito H; Suhara T
    Int J Neuropsychopharmacol; 2017 Nov; 20(11):928-935. PubMed ID: 29016872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antipsychotic-associated mental side effects and their relationship to dopamine D2 receptor occupancy in striatal subdivisions: a high-resolution PET study with [11C]raclopride.
    Kim JH; Son YD; Kim HK; Lee SY; Cho SE; Kim YB; Cho ZH
    J Clin Psychopharmacol; 2011 Aug; 31(4):507-11. PubMed ID: 21694619
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A therapeutic approach to tardive dyskinesia.
    Fahn S
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):19-24. PubMed ID: 2858474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetic analysis of central [76Br]bromolisuride binding to dopamine D2 receptors studied by PET.
    Delforge J; Loc'h C; Hantraye P; Stulzaft O; Khalili-Varasteh M; Mazière M; Syrota A; Mazière B
    J Cereb Blood Flow Metab; 1991 Nov; 11(6):914-25. PubMed ID: 1834685
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
    Seeman P; Guan HC; Niznik HB
    Synapse; 1989; 3(1):96-7. PubMed ID: 2521961
    [No Abstract]   [Full Text] [Related]  

  • 57. Iodoethylspiperone, a new potential agent for exploration of central dopamine D2 receptors: synthesis and preliminary in vivo study.
    Chalon S; Frangin Y; Guilloteau D; Caillet M; Guimbal C; Schmitt MH; Desplanches G; Baulieu JL; Besnard JC
    Int J Rad Appl Instrum B; 1990; 17(4):389-95. PubMed ID: 2143754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
    Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
    Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. No involvement of the adenosine A2A receptor in tardive dyskinesia in Russian psychiatric inpatients from Siberia.
    Ivanova SA; Al Hadithy AF; Brazovskaya N; Semke A; Wilffert B; Fedorenko O; Brouwers JR; Loonen AJ
    Hum Psychopharmacol; 2012 May; 27(3):334-7. PubMed ID: 22585593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine D2 receptor density estimates in schizophrenia: a positron emission tomography study with 11C-N-methylspiperone.
    Tune LE; Wong DF; Pearlson G; Strauss M; Young T; Shaya EK; Dannals RF; Wilson AA; Ravert HT; Sapp J
    Psychiatry Res; 1993 Dec; 49(3):219-37. PubMed ID: 7909948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.